23 January 2023

Smit MJ et al. Lancet Microbe (in press)

Smit MJ, Sander AF, Ariaans MB, Fougeroux C, Heinzel C, Fendel R, Esen M, Kremsner PG, ter Heine R, Wertheim HF, Idorn M, Paludan SR, Underwood AP, Binderup A, Ramirez S, Bukh J, Soegaard M, Erdogan SM, Gustavsson T, Clemmensen S, Theander TG, Salanti A, Hamborg M, de Jongh WA, McCall MB, Nielsen MA and Mordmüller BG. First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2. [PubMed]

Lancet Microbe logo

Topics